Search

everythinglearnresearchcommunity

for

Search:↓

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Young adults with hair loss face higher risk of stiff arteries.

The study concluded that certain hair growth measurements are good indicators of baldness severity and provide a more accurate assessment than subjective grading.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

Alopecia areata patients are more likely to have thyroid disorders than healthy individuals.

Autosomal recessive woolly hair is rare and involves tightly coiled hair without other health issues.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Telogen effluvium most affects quality of life in alopecia patients.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

People with alopecia areata often have thyroid autoimmunity.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

The DLQI is reliable but may not fully capture the impact of skin conditions on quality of life, especially in emotional and psychological areas.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Lower 2D:4D ratio and older age increase the risk of severe hair loss in men.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Targeting the AhR pathway may help treat alopecia areata.

People with alopecia areata have more inflammation but similar heart risk as healthy people.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Sinclair grading effectively identifies female androgenic alopecia patterns, with Grade III most common.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

The conclusion is that a safe donor area for hair transplants varies and should be chosen based on individual factors like race, future hair loss, family history, and specific thinning patterns.

The research explored how children in school view peers with alopecia areata.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

Testosterone levels don't predict acne severity in adult women.